tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:38I Stock Latest News

NTLA Upcoming Earnings Report: What to Expect?
Pre-EarningsNTLA Upcoming Earnings Report: What to Expect?
1d ago
NTLA
Intellia Therapeutics reports inducment grants
PremiumThe Fly
Intellia Therapeutics reports inducment grants
12d ago
NTLA
Intellia Therapeutics price target raised to $7 from $4 at Baird’
PremiumThe Fly
Intellia Therapeutics price target raised to $7 from $4 at Baird’
21d ago
NTLA
Intellia Therapeutics price target raised to $25 from $15 at H.C. Wainwright
PremiumThe Fly
Intellia Therapeutics price target raised to $25 from $15 at H.C. Wainwright
21d ago
NTLA
Citizens says nex-z return to clinic should add ‘significant value’ to Intellia
PremiumThe Fly
Citizens says nex-z return to clinic should add ‘significant value’ to Intellia
22d ago
NTLA
Intellia up 24% in premarket at $17.34 as FDA lifts hold on nex-z Phase 3 study
PremiumThe FlyIntellia up 24% in premarket at $17.34 as FDA lifts hold on nex-z Phase 3 study
22d ago
NTLA
FDA Lifts Hold on Intellia’s MAGNITUDE-2 Trial
Premium
Company Announcements
FDA Lifts Hold on Intellia’s MAGNITUDE-2 Trial
22d ago
8K
NTLA
Intellia Therapeutics announces FDA lift of clinical hold on MAGNITUDE-2 trial
Premium
The Fly
Intellia Therapeutics announces FDA lift of clinical hold on MAGNITUDE-2 trial
22d ago
NTLA
Cathie Wood’s ARK Investment buys 57K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 57K shares of Intellia Therapeutics today
1M ago
NTLA
Cathie Wood’s ARK Investment buys 40K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 40K shares of Intellia Therapeutics today
1M ago
NTLA
Balancing Promise and Uncertainty: Justifying a Hold on Intellia Ahead of Key Late‑Stage Readouts
PremiumRatings
Balancing Promise and Uncertainty: Justifying a Hold on Intellia Ahead of Key Late‑Stage Readouts
1M ago
NTLA
Intellia Updates Investors on Nex-Z Trial Safety Hold
PremiumCompany Announcements
Intellia Updates Investors on Nex-Z Trial Safety Hold
1M ago
8K
NTLA
Intellia Therapeutics price target lowered to $12 from $14 at BofA
PremiumThe FlyIntellia Therapeutics price target lowered to $12 from $14 at BofA
1M ago
NTLA
Citizens JMP healthcare analysts hold an analyst/industry conference
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference
3M ago
BNTC
CRSP
Intellia Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Intellia Therapeutics Reports Q3 2025 Financial Results
3M ago
NTLA
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
PremiumThe Fly
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
3M ago
C
T
Carvana initiated, AT&T upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Carvana initiated, AT&T upgraded: Wall Street’s top analyst calls
3M ago
T
AN
Wolfe downgrades Intellia to Peer Perform on Nex-z safety issue
PremiumThe Fly
Wolfe downgrades Intellia to Peer Perform on Nex-z safety issue
3M ago
NTLA
Intellia Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
PremiumThe Fly
Intellia Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
3M ago
NTLA
FDA appoints Richard Pazdur as Director of CDER
PremiumThe FlyFDA appoints Richard Pazdur as Director of CDER
3M ago
AZN
BMY
Intellia Therapeutics downgraded to Hold from Buy at JonesResearch
Premium
The Fly
Intellia Therapeutics downgraded to Hold from Buy at JonesResearch
3M ago
NTLA
Intellia Therapeutics downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Intellia Therapeutics downgraded to In Line from Outperform at Evercore ISI
3M ago
NTLA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >